Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Stock
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.57 TRY | -1.72% | -4.70% | +0.96% |
Sales 2021 | 410M 12.74M | Sales 2022 | 269M 8.35M | Capitalization | 4.74B 147M |
---|---|---|---|---|---|
Net income 2021 | 433M 13.45M | Net income 2022 | 330M 10.25M | EV / Sales 2021 | 6.59 x |
Net cash position 2021 | 511M 15.86M | Net cash position 2022 | 411M 12.77M | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 |
5.1
x | P/E ratio 2022 |
14.3
x | Employees | 171 |
Yield 2021 * |
-
| Yield 2022 |
2.76% | Free-Float | 25.33% |
1 day | -1.72% | ||
1 week | -4.70% | ||
Current month | -5.35% | ||
1 month | -11.23% | ||
3 months | -9.70% | ||
6 months | -9.63% | ||
Current year | +0.96% |
Managers | Title | Age | Since |
---|---|---|---|
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 12.57 | -1.72% | 1,804,230 |
24-05-23 | 12.79 | -1.92% | 2,016,187 |
24-05-22 | 13.04 | +2.44% | 2,053,886 |
24-05-21 | 12.73 | -5.49% | 3,581,341 |
24-05-20 | 13.47 | +2.12% | 2,414,510 |
Delayed Quote Borsa Istanbul, May 24, 2024 at 11:09 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+0.96% | 85.84M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ANGEN Stock